Please wait while the formulary information is being retrieved.
VIVARIN (CAFFEINE)
- Drowsy
- Fatigue
- Vivarin Tablet
- Vivarin Tab
- Stay Awake Tablet
- Stay Awake Maximum Strength Tablet
- Caffeine Tablet
- Awake Tablet
200 mg tablet
- Dosage information is not available
200 mg tablet
- Dosage information is not available
200 mg tablet
- Dosage information is not available
Maximum Strength 200 mg tablet
- Dosage information is not available
200 mg tablet
- Dosage information is not available
200 mg tablet
- Dosage information is not available
- dipyridamole
Contraindicated
- Acid Reducer (cimetidine)
- Acid Relief (cimetidine)
- Adenocard
- Adenoscan
- adenosine
- adenosine (diagnostic)
- cimetidine
- Heartburn Relief
- Lexiscan
- regadenoson
- Tagamet Hb
Severe
Moderate
- fluvoxamine
- lithium carbonate
- lithium citrate
- Lithobid
- Luvox Cr
- 30 day risk period post-myocardial infarction
Contraindicated
- Necrotizing enterocolitis
- Peptic ulcer
Severe
Moderate
- Cardiac arrhythmia
- Hypertension
- Insomnia
- Renal disease with moderate to severe impairment
- Seizure disorder
- Severe hepatic disease
VIVARIN (CAFFEINE)
- Drowsy
- Fatigue
- None
- Gastrointestinal irritation
- Insomnia
- Nervousness
More Frequent
Severe
Less Severe
- None
- Excitement
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Extrasystoles
Less Severe
- Agitation
- Hyperesthesia
- Hyperglycemia
- Irritability
- Nausea
- Nephrotoxicity
- Scotomata
- Symptoms of anxiety
- Tachycardia
- Tinnitus
- Tremor
- Vomiting
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Caffeine
Caution in: seizure disorder, cardiovascular disease, or in premature neonates with renal or hepatic impairment.
Adverse CNS effects of insomnia, restlessness, nervousness, and mild delirium, more severe in children.
- 1 Day – 364 Days
- Caution in: seizure disorder, cardiovascular disease, or in premature neonates with renal or hepatic impairment.
- Adverse CNS effects of insomnia, restlessness, nervousness, and mild delirium, more severe in children.
- 1 Years – 13 Years
- Caution in: seizure disorder, cardiovascular disease, or in premature neonates with renal or hepatic impairment.
- Adverse CNS effects of insomnia, restlessness, nervousness, and mild delirium, more severe in children.
Caffeine
- Severity Level:
C
- Additional Notes: Reports of miscarriage,poor fetal growth possibly assoc w/high doses of caffeine
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Caffeine
High doses may cause hyperactivity and wakefulness in infant.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Drug shown to have adverse effect | High doses may cause hyperactivity and wakefulness in infant. |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Drowsy | |
| R40.0 | Somnolence |
| Fatigue | |
| R53.82 | Chronic fatigue, unspecified |
| R53.83 | Other fatigue |
| 0-9 | A-Z |
|---|---|
| R40.0 | Somnolence |
| R53.82 | Chronic fatigue, unspecified |
| R53.83 | Other fatigue |
Formulary Reference Tool